首页> 外文期刊>Journal of Medicinal Chemistry >Novel [~(99)mTc~(III)(PS)_2(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc~(III)-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies
【24h】

Novel [~(99)mTc~(III)(PS)_2(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc~(III)-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies

机译:新型[〜(99)mTc〜(III)(PS)_2(Ln)]混合配体化合物(PS =硫代膦酸酯; L =二硫代氨基甲酸酯),可用于设计和开发基于Tc〜(III)的试剂:体外和体内生物分布研究

获取原文
获取原文并翻译 | 示例
           

摘要

A general procedure for the preparation of a new class of neutral six-coordinated mixed ligand [~(99)mTc~(III)(PS)_2(Ln)] compounds (PS = trisalkyl-phosphinothiolate; Ln = dithiocarbamate) is reported as well as their in vitro stability and the ex vivo tissue distribution studies. [~(99)mTc(PS)_2(Ln)] complexes were prepared in high yield in nearly physiologic conditions following a one-pot procedure. For instance, the chemical identity of [~(99)mTc(PSiso)_2(L1)] (PSiso = 2-(diisopropylphosphino)ethanethiol; L1 = pyrrolidine dithiocarbamate) was determined by HPLC comparison with the corresponding 99gTc-complex. All complexes comprise the stable [~(99)mTc~(III)(PS)_2]~+ moiety, where the remaining two coordination positions are saturated by a dithiocarbamate chelate, also carrying bioactive molecules (e.g., 2-methoxyphenylpiperazine). [~(99)mTc(PS)_2(Ln)] complexes were inert toward ligand exchange reactions. No significant in vitro and in vivo biotransformation were observed, underlining their remarkable thermodynamic stability and kinetic inertness. These results could be conveniently utilized to devise a novel class of ~(99)mTc~(III)-based compounds useful in radiopharmaceutical applications.
机译:据报道,制备新型中性六配位混合配体[〜(99)mTc〜(III)(PS)_2(Ln)]化合物(PS =三烷基膦硫醇盐; Ln =二硫代氨基甲酸酯)的一般程序为以及它们的体外稳定性和离体组织分布研究。 [〜(99)mTc(PS)_2(Ln)]复合物是按照一锅法在几乎生理条件下高产率制备的。例如,通过HPLC与相应的99gTc-络合物的比较,确定了[〜(99)mTc(PSiso)_2(L1)](PSiso = 2-(二异丙基膦基)乙硫醇; L1 =吡咯烷二硫代氨基甲酸酯)的化学同一性。所有复合物均包含稳定的[〜(99)mTc〜(III)(PS)_2] +部分,其中其余的两个配位位置被二硫代氨基甲酸酯螯合物饱和,还带有生物活性分子(例如2-甲氧基苯基哌嗪)。 [〜(99)mTc(PS)_2(Ln)]配合物对配体交换反应呈惰性。没有观察到明显的体外和体内生物转化,突显了其显着的热力学稳定性和动力学惰性。这些结果可方便地用于设计一类新型的〜(99)mTc〜(III)基化合物,可用于放射性药物应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号